Geoffrey Alan Donnan

机构：The Royal Melbourne Hospital, The University of Melbourne, Melbourne Health · ORCID：0000-0001-6324-3403

发表论文 1276 篇 · 总被引 102939 次 · h-index 141

代表论文

• Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial (2024 · The Lancet Neurology · 被引 96)
• Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial (2024 · The Lancet Neurology · 被引 48)
• Persistent Tissue-Level Hypoperfusion (No-Reflow) Negates the Clinical Benefit of Successful Thrombectomy (2025 · Stroke · 被引 31)
• Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial (2025 · European Heart Journal · 被引 22)
• Intracranial Hemorrhage in Patients With Stroke After Endovascular Treatment With or Without IV Alteplase (2025 · JAMA Neurology · 被引 16)
• Tranexamic Acid Within 4.5 Hours of Intracerebral Hemorrhage With the CTA Spot Sign (2024 · Neurology · 被引 16)